RxDoctor Payments Data

Veronica Perez, APRN

Family · Miami, FLNPI 1013552397

Payments from drug & device makers

$2,277in general payments, 2019–2025

Across 118 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$642
  • Boehringer Ingelheim$331
  • GSK$303
  • Lilly USA, LLC$289
  • Pfizer$150
  • AstraZeneca$144
  • plus $419 from 9 others

What the payments were for

  • Food & beverage$2,277100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,277 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$5,766
Medicare patients
46
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$36,124
ProliaDenosumab13$22,435
RybelsusSemaglutide12$11,686
EliquisApixaban12$10,064
JardianceEmpagliflozin11$6,391
Diclofenac Sodium40$900
Rosuvastatin Calcium45$694
Famotidine27$692
Omeprazole40$595
Levothyroxine Sodium80$543
Atorvastatin Calcium90$474
Fluticasone Propionate33$410
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav38$337
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst20$330
Albuterol Sulfate HfaAlbuterol Sulfate18$328

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$642$47,81044 claims
AmgenProlia$17$22,43513 claims
PfizerEliquis$150$10,06412 claims
Boehringer IngelheimJardiance$331$6,39111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 14,618 family providers in Florida.

Other family in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →